RxDoctor Payments Data

Eastlyn Harding-Marin, MD

Family Medicine · Ellenwood, GANPI 1912944083

Payments from drug & device makers

$2,626in general payments, 2019–2025

Across 23 payments — averaging $114.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • Abbott$275
  • Novo Nordisk$273
  • Exact Sciences$29
  • AstraZeneca$21
  • Bayer$16
  • plus $13 from 1 others

What the payments were for

  • Consulting fees$2,27587%
  • Food & beverage$35113%

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer1$2,000
Abbott1$275
Novo Nordisk16$273
Exact Sciences2$29
AstraZeneca1$21
Bayer1$16
IBSA Pharma Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,626 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$7,189
Medicare patients
19
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$74,763
JanuviaSitagliptin Phosphate13$20,162
EliquisApixaban14$10,296
Combivent RespimatIpratropium/Albuterol Sulfate13$6,404
Memantine Hcl ErMemantine Hcl24$2,779
Duloxetine Hcl40$2,215
Colchicine20$1,815
Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide104$1,595
Levocetirizine Dihydrochloride130$1,404
Atorvastatin Calcium187$1,297
Albuterol Sulfate HfaAlbuterol Sulfate43$1,287
Diclofenac Sodium28$1,210
Glipizide106$1,134
Gabapentin59$1,075
Fluticasone Propionate124$995

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$273$74,76358 claims
PfizerEliquis$2,000$10,29614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Ellenwood

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →